Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer

Por Enzinger, P. C., Ryan, D. P., Clark, J. W., Muzikansky, A., Earle, C. C., Kulke, M. H., Meyerhardt, J. A., Blaszkowsky, L. S., Zhu, A. X., Fidias, P., Vincitore, M. M., Mayer, R. J., Fuchs, C. S.
Publicado em 2009

A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma

Por Chan, J. A., Blaszkowsky, L. S., Enzinger, P. C., Ryan, D. P., Abrams, T. A., Zhu, A. X., Temel, J. S., Schrag, D., Bhargava, P., Meyerhardt, J. A., Wolpin, B. M., Fidias, P., Zheng, H., Florio, S., Regan, E., Fuchs, C. S.
Publicado em 2011

Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer

Por Blaszkowsky, L. S., Ryan, D. P., Szymonifka, J., Borger, D. R., Zhu, A. X., Clark, J. W., Kwak, E. L., Mamon, H. J., Allen, J. N., Vasudev, E., Shellito, P. C., Cusack, J. C., Berger, D. L., Hong, T. S.
Publicado no Ann Oncol (2014)

Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer(†)

Por Wolpin, B. M., O'Reilly, E. M., Ko, Y. J., Blaszkowsky, L. S., Rarick, M., Rocha-Lima, C. M., Ritch, P., Chan, E., Spratlin, J., Macarulla, T., McWhirter, E., Pezet, D., Lichinitser, M., Roman, L., Hartford, A., Morrison, K., Jackson, L., Vincent, M., Reyno, L., Hidalgo, M.
Publicado em 2013

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer

Por Hezel, A F, Noel, M S, Allen, J N, Abrams, T A, Yurgelun, M, Faris, J E, Goyal, L, Clark, J W, Blaszkowsky, L S, Murphy, J E, Zheng, H, Khorana, A A, Connolly, G C, Hyrien, O, Baran, A, Herr, M, Ng, K, Sheehan, S, Harris, D J, Regan, E, Borger, D R, Iafrate, A J, Fuchs, C, Ryan, D P, Zhu, A X
Publicado em 2014